Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Intellia Therapeutics (NTLA) Asset Utilization Ratio (2016 - 2026)

Intellia Therapeutics has reported Asset Utilization Ratio over the past 11 years, most recently at 0.08 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 97.25% to 0.08 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.08 through Mar 2026, up 97.25% year-over-year, with the annual reading at 0.07 for FY2025, 43.31% up from the prior year.
  • Asset Utilization Ratio was 0.08 for Q1 2026 at Intellia Therapeutics, up from 0.08 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.08 in Q1 2026 and troughed at 0.02 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.04 (2023), against an average of 0.05.
  • The largest YoY upside for Asset Utilization Ratio was 136.33% in 2022 against a maximum downside of 66.48% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2022, then dropped by 28.75% to 0.03 in 2023, then surged by 71.69% to 0.05 in 2024, then skyrocketed by 56.41% to 0.08 in 2025, then increased by 7.82% to 0.08 in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Asset Utilization Ratio are 0.08 (Q1 2026), 0.08 (Q4 2025), and 0.06 (Q3 2025).